12/9
07:21 am
rapp
Rapport Therapeutics (NASDAQ:RAPP) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Medium
Report
Rapport Therapeutics (NASDAQ:RAPP) had its "buy" rating reaffirmed by analysts at HC Wainwright.
12/8
08:07 am
rapp
Rapport Therapeutics (NASDAQ:RAPP) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $47.00 price target on the stock.
Low
Report
Rapport Therapeutics (NASDAQ:RAPP) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $47.00 price target on the stock.
12/8
05:45 am
rapp
Rating for RAPP
Low
Report
Rating for RAPP
11/20
06:02 am
rapp
Rapport Therapeutics (NASDAQ:RAPP) was upgraded by analysts at BTIG Research to a "strong-buy" rating.
Low
Report
Rapport Therapeutics (NASDAQ:RAPP) was upgraded by analysts at BTIG Research to a "strong-buy" rating.
11/19
08:07 am
rapp
Rapport Therapeutics (NASDAQ:RAPP) is now covered by analysts at BTIG Research. They set a "buy" rating and a $47.00 price target on the stock.
Medium
Report
Rapport Therapeutics (NASDAQ:RAPP) is now covered by analysts at BTIG Research. They set a "buy" rating and a $47.00 price target on the stock.
11/19
05:04 am
rapp
Rating for RAPP
Medium
Report
Rating for RAPP
11/18
04:16 pm
rapp
Rapport Therapeutics initiated with a Buy at BTIG
Medium
Report
Rapport Therapeutics initiated with a Buy at BTIG